ANI PHARMACEUTICALS INC (ANIP) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00182C1036
ANI PHARMACEUTICALS INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 883.37 m USD |
| Gross profit | 542.06 m USD |
| Operating income | 111.09 m USD |
| EBIT | 128.35 m USD |
| Net income | 78.34 m USD |
| Diluted EPS – continuing operations | 3.32 USD |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ANI PHARMACEUTICALS INC
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
More stocks
- Sesa SpA (SES.MI)
- Chongqing Iron & Steel Co Ltd Class A (601005.SS)
- HYCROFT MINING HOLDING CORP (HYMC)
- i-Tail Corp. PCL (ITC.BK)
- Implenia AG (IMPN.SW)
- Caisse Reg Credit Agric Mut Nord France (CNDF.PA)
- JF SmartInvest Holdings Ltd (9636.HK)
- Nationwide Building Society (NBS.L)
- ECOPRO MAT (450080.KS)
- MR. D.I.Y. Holding (Thailand) Public Company Limited (MRDIYT.BK)
- BW Energy Ltd (BWE.OL)
- Electrolux Professional AB (publ) (EPRO B.ST)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.